July 3, 2023

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

Sue Peschin – FDA, CMS, and Alzheimer’s Drugs: What Do American Voters Want?

About This Episode

Should Alzheimer’s drugs be treated like all other drugs when it comes to Medicare coverage? The Alliance for Aging Research CEO Sue Peschin and BrainStorm host Meryl Comer dive into polling data that reveals most American voters, regardless of party, disagree with CMS’s policy that will limit access. Their conversation sheds light on how the coverage decision, if it stands, will create not only greater disparities, but also have wide-ranging implications on coverage for other disease-modifying therapies. 

This episode is sponsored by Eisai.

Support the show

BrainStorm Feed

82

Doreen Monks – The Emotional Journey of Alzheimer’s and Dementia (part 1)

What if your life and career were upended with a diagnosis of Alzheimer’s only to learn eight years later that the diagnosis was wrong?  In th

LISTEN NOW
81

Tony Bennett's Daughters - Breaking Through the Silence of Alzheimer's

Learning about an Alzheimer’s diagnosis in your family is never easy.

LISTEN NOW
80

George Vradenburg and the Global Impact of Alzheimer's (part 1)

Alzheimer’s is not just an aging issue, but a lifelong brain health challenge that has major global, economic, and societal implications.

LISTEN NOW